CTLA4 and neoplasm: In order to determine the prevalence of CTLA-4+ lymphocytes in a broad range of different tumor entities, a set of preexisting tissue microarrays (TMAs) was analyzed that included >4000 tumor samples from 90 types and subtypes as well as 76 different normal tissue categories.